Literature DB >> 1719434

Subtypes and excitation-contraction coupling mechanisms for neurokinin receptors in smooth muscle of the guinea-pig Taenia caeci.

J M Hall1, I K Morton.   

Abstract

This study investigated the subtype and coupling mechanisms mediating the direct contractile response to tachykinins in the guinea-pig Taenia caeci preparation in vitro. Coupling of neurokinin receptors was compared throughout with coupling of muscarinic receptors. The smooth muscle neurokinin receptors seem to be predominantly of the NK-1 subtype. Thus, the relative activities of the common naturally-occurring tachykinins fell within one order of magnitude, and the selective NK-1 receptor agonist substance P methyl ester was high in activity (0.38 relative to substance P). Some contribution from NK-3 receptors is, however, possible in view of the appreciable activity of the selective NK-3 agonist succ-[Asp6, N-MePhe8]-SP(6-11) (senktide; activity 0.004 relative to substance P), and NK-2 or NK-3 receptors in view of the higher activity of the D-isomer of [Glp6, *Pro9]-SP(6-11) as compared to its NK-1 selective L-isomer (D/L-activity ratio 1.53). Contractile actions of tachykinins were compared with carbachol for reliance on membrane-potential dependent (electromechanical) and membrane-potential independent (pharmacomechanical) coupling mechanisms. Log concentration-response curves to carbachol and substance P in normal Krebs' medium were compared with curves obtained in a high-K+ solution where processes dependent on changes in membrane potential could play no part in excitation. In the high-K+ depolarizing solution, a concentration-related relationship was maintained, though with some diminution in the maximal additional tension generated: the maximum tension with carbachol was under both conditions greater than that with substance P. The relative effects of several tachykinins and carbachol in producing receptor-mediated changes in membrane permeability through presumed receptor-operated ion channel opening, was estimated in terms of the ability to increase 86Rb-efflux, as a marker for K+, in a high-K+ depolarizing solution. Carbachol (10 microM) consistently increased 86Rb-efflux. In contrast, no permeability increase could be detected with any tachykinin tested (substance P, eledoisin, substance P methyl ester, neurokinin A, neurokinin B, 1 or 10 microM). Tachykinins and carbachol were compared in terms of ability to increase phosphatidylinositol hydrolysis. Both substance P and carbachol showed a concentration-related increase in accumulation of total inositol phosphates; though the maximal response to carbachol was considerably greater than that to any tachykinin (substance P, eledoisin, substance P methyl ester, senktide, neurokinin A, neurokinin B), or combination of two tachykinins (substance P and eledoisin, senktide and substance P methyl ester).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719434     DOI: 10.1007/bf00167223

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  51 in total

1.  The effect of carbachol on the permeability of depolarized smooth muscle to inorganic ions.

Authors:  R P DURBIN; D H JENKINSON
Journal:  J Physiol       Date:  1961-06       Impact factor: 5.182

2.  Changes in configuration of spontaneously discharged spike potentials from smooth muscle of the guinea-pig's taenia coli; the effect of electrotonic currents and of adrenaline, acetylcholine and histamine.

Authors:  E BULBRING
Journal:  J Physiol       Date:  1957-02-15       Impact factor: 5.182

3.  The action of acetylcholine and other drugs on the efflux of potassium and rubidium from smooth muscle of the guinea-pig intestine.

Authors:  A S Burgen; L Spero
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

Review 4.  Inositol trisphosphate, calcium and muscle contraction.

Authors:  A P Somlyo; J W Walker; Y E Goldman; D R Trentham; S Kobayashi; T Kitazawa; A V Somlyo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1988-07-26       Impact factor: 6.237

5.  Smooth muscle cell junctions and structural aspects of contraction.

Authors:  G Gabella
Journal:  Br Med Bull       Date:  1979-09       Impact factor: 4.291

6.  Substance P can contract the longitudinal muscle of the guinea-pig small intestine by releasing intracellular calcium.

Authors:  P Holzer; I T Lippe
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

7.  Investigation of the relationship between cell-surface calcium-ion gating and phosphatidylinositol turnover by comparison of the effects of elevated extracellular potassium ion concentration on ileium smooth muscle and pancreas.

Authors:  S S Jafferji; R H Michell
Journal:  Biochem J       Date:  1976-11-15       Impact factor: 3.857

8.  Neuromuscular blocking agents inhibit receptor-mediated increases in the potassium permeability of intestinal smooth muscle.

Authors:  P R Gater; D G Haylett; D H Jenkinson
Journal:  Br J Pharmacol       Date:  1985-12       Impact factor: 8.739

9.  Comparison of the effects of some muscarinic agonists on smooth muscle function and phosphatidylinositol turnover in the guinea-pig taenia caeci.

Authors:  A L Gardner; L K Choo; F Mitchelson
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

10.  Comparison of potency of substance P and related peptides on [3H]-acetylcholine release, and contractile actions, in the guinea-pig ileum.

Authors:  P Fosbraey; R L Featherstone; I K Morton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

View more
  2 in total

1.  Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.

Authors:  J L Field; S K Butt; I K Morton; J M Hall
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

2.  Bradykinin receptors in the guinea-pig taenia caeci are similar to proposed BK3 receptors in the guinea-pig trachea, and are blocked by HOE 140.

Authors:  J L Field; J M Hall; I K Morton
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.